Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy

George Fromm(Lemuel Shattuck Hospital), Taylor H. Schreiber(Lemuel Shattuck Hospital)
Journal for ImmunoTherapy of Cancer
December 1, 2018
Cited by 49


Related Papers